- Short Communication
- Published:
Inhibitory effects of dicaffeoylquinic acids from Artemisia dubia on aldo-keto reductase family 1b10
Journal of the Korean Society for Applied Biological Chemistry volume 53, pages 826–830 (2010)
Abstract
The ethyl acetate fraction of Artemisia dubia showed a potent inhibitory activity on recombinant human AKR1B10 (rh AKR1B10). Due to its potency, subsequent purification of ethyl acetate fraction led to seven compounds including five dicaffeoylquinic acid (DCQA) derivatives. Compounds were identified as 3,4-dihydroxybenzoic acid (1), quercetin 3-O-β-glucose (2), 3,4-DCQA (3), 3,5-DCQA (4), 4,5-DCQA (5), 3,5-DCQA methyl ester (6), and 4,5-DCQA methyl ester (7). A series of DCQA derivatives (3-7) showed inhibitory activity on rhAKR1B10 in the range of IC50 1.24-2.29 μM, whereas 3,4-dihydroxybenzoic acid and quercetin 3-O-β-glucose showed no inhibitory activity on rhAKR1B10.
References
Basnet P, Matsushige K, Hase K, Kadota S, and Namba T (1996) Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 19, 1479–1484.
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813–820.
Cao D, Fan ST, and Chung SS (1998) Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem 273, 11429–11435.
Crosas B, Hyndman DJ, Gallego O, Martras S, Pares X, Flynn TG, and Farres J (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J 373, 973–979.
de la Fuente JA, and Manzanaro S (2003) Aldose reductase inhibitors from natural sources. Nat Prod Rep 20, 243–251.
Dhingra V, Vishweshwar RK, and Lakshmi NM (2000) Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci 66, 279–300.
Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, Taniguchi H, Ishikawa S, Ito H, Yamamoto S, Iwanari H, Hironaka M, Ishikawa Y, Niki T, Sohara Y, Kodama T, Nishimura M, Fukayama M, Dosaka-Akita H, and Aburatani H (2005) Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers’ non-small cell lung carcinomas. Clin Cancer Res 11, 1776–1785.
Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, and Tannapfel A (2010) Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours. J Hepatol 52, 220–227.
Iwai K, Kishimoto N, Kakino Y, Mochida K, and Fujita T (2004) In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. J Agric Food Chem 52, 4893–4898.
Kim JY, Kim DY, Lee YS, Lee BK, Lee KH, and Ro JY (2006) DA-9601, Artemisia asiatica herbal extract, ameliorates airway inflammation of allergic asthma in mice. Mol Cells 22, 104–112.
Kurata R, Adachi M, Yamakawa O, and Yoshimoto M (2007) Growth suppression of human cancer cells by polyphenolics from sweetpotato (Ipomoea batatas L.) leaves. J Agric Food Chem 55, 185–190.
Lai H, and Singh NP (2006) Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett 231, 43–48.
Lee JY, Song DG., Lee EH, Jung SH, Nho CW, Cha KH, and Pan CH (2009) Inhibitory Effects of 3,5-O-Dicaffeoyl-epi-quinic Acid from Gymnaster koraiensis on AKR1B10. J Korean Soc Appl Biol Chem 52, 731–734.
Ma J, Yan R, Zu X, Cheng JM, Rao K, Liao DF, and Cao D (2008) Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem 283, 3418–3423.
Martin HJ, Breyer-Pfaff U, Wsol V, Venz S, Block S, and Maser E (2006) Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab Dispos 34, 464–470.
Ntutela S, Smith P, Matika L, Mukinda J, Arendse H, Allie N, Estes DM, Mabusela W, Folb P, Steyn L, Johnson Q, Folk WR, Syce J, and Jacobs M (2009) Efficacy of Artemisia afra phytotherapy in experimental tuberculosis. Tuberculosis (Edinb) 89 Suppl 1, S33–40.
Song DG, Lee JY, Lee EH, Jung SH, Nho CW, Cha KH, Koo SY, and Pan CH (2010) Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10. BMB Reports 43, 268–272.
Teng RW, Wang DZ, Wu YS, Lu Y, Zheng QT, and Yang CR (2005) NMR assignments and single-crystal X-ray diffraction analysis of deoxyloganic acid. Magn Reson Chem 43, 92–96.
Wang C, Yan R, Luo D, Watabe K, Liao DF, and Cao D (2009) Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem 284, 26742–26748.
Yan R, Zu X, Ma J, Liu Z, Adeyanju M, and Cao D (2007) Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention. Int J Cancer 121, 2301–2306.
Yoshitake H, Takahashi M, Ishikawa H, Nojima M, Iwanari H, Watanabe A, Aburatani H, Yoshida K, Ishi K, Takamori K, Ogawa H, Hamakubo T, Kodama T, and Araki Y (2007) Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int J Gynecol Cancer 17, 1300–1306.
Author information
Authors and Affiliations
Corresponding author
Additional information
These three authors contribute equally to this work.
Rights and permissions
About this article
Cite this article
Lee, H.J., Lee, J.Y., Kim, S.M. et al. Inhibitory effects of dicaffeoylquinic acids from Artemisia dubia on aldo-keto reductase family 1b10. J. Korean Soc. Appl. Biol. Chem. 53, 826–830 (2010). https://doi.org/10.3839/jksabc.2010.125
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.3839/jksabc.2010.125